Communiqués Biosenta Inc.

Actions

ZRO

CA09072N2023

Produits ménagers

Marché Fermé - Canadian Securities Exchange 21:12:37 31/08/2026			Varia. 5j.	Varia. 1 janv.
0,0550 ^CAD	-.--%		-.--%	-45,00%

28/08	Biosenta Inc. publie ses résultats pour le troisième trimestre et les neuf mois clos le 30 juin 2026	CI
21/07	Biosenta Inc. met en avant les recherches de l'Université de Calgary validant la technologie antimicrobienne Tri-Filler	CI

Communiqués

17/08	Secretary of State Randeep Sarai Visits University of Calgary to Learn About Biosenta's Tri-Filler(TM) Technology	AQ
14/08	Secretary of State Randeep Sarai Visits University of Calgary to Learn About Biosenta's Tri-Filler(TM) Technology	NE
21/07	Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology	NE
11/12	Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build	NE
01/10/25	Former Canadian Coatings Association President & CEO Gary LeRoux joins Biosenta's Advisory Board	NE
21/07/25	Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor	NE
11/06/25	Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies	NE
10/06/24	Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability	NE
08/05/24	Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions	NE
27/04/24	Biosenta Closes Private Placement Financing	NE
19/04/24	Biosenta Announces Private Placement Financing	NE
27/03/24	Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology	NE
22/02/24	Amarvir Gill Holdings in Biosenta Inc.	NE
21/02/24	Biosenta Announces Closing of Previously Announced Transaction	NE
31/01/24	Biosenta Announces Debt Settlement	NE
11/01/24	Biosenta Announces Engagement of Oak Hill Financial Inc.	NE
27/12/23	Biosenta Closes Private Placement Financing	NE
15/12/23	Biosenta Announces Private Placement Financing	NE
28/09/23	Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs	GL
06/09/23	Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™	GL
08/08/23	Canadian Investment Regulatory Organization Trade Resumption - ZRO	AQ
08/08/23	Biosenta announces further advances in research and development of Tri-Filler™	GL
08/08/23	Canadian Investment Regulatory Organization Trading Halt - ZRO	AQ
17/07/23	Biosenta Announces Termination of Joint Venture and Issuance of Securities	GL
23/06/23	Biosenta Announces Entering Into of Agreement to Terminate Joint Venture	GL